Lv4
410 积分 2025-01-03 加入
First-Line Zongertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
1天前
已完结
Metastatic Trajectories in Non–Small Cell Lung Cancer Guide Local and Systemic Therapies
2天前
已完结
Acquired Resistance to Immune Checkpoint Inhibitors Across Tumor Types: A Reconstructed Individual Patient Data Analysis
2天前
已完结
NSCLC: Five trials to watch
5天前
已完结
Outcomes and Treatments of Patients With Non–Small Cell Lung Cancer Who Received Pembrolizumab
5天前
已完结
Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12C mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials
10天前
已完结
Individual Patient Data Meta-Analysis of Consensus Molecular Subtypes as Biomarkers of First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer
10天前
已完结
Decline of PD-L1 Immunoreactivity with Storage Duration in Formalin-Fixed Paraffin-Embedded Breast Cancer Specimens: Implications for Diagnostic Accuracy and Immunotherapy Eligibility in Triple-Negative Breast Cancer
10天前
已完结
Protective effect of bevacizumab against interstitial lung disease in non-squamous non-small-cell lung cancer: a nationwide target trial emulation study
11天前
已关闭
Clinical outcomes and tumor immune microenvironment in SMARCA4-Deficient NSCLC: A Real-World retrospective study
11天前
已关闭
皖公网安备34019202002308
